A Science-published study shows Microsoft's diagnostic system outperforming generalist physicians, though the underlying models — not Microsoft's orchestration — drove most gains.
Microsoft AI CEO Mustafa Suleyman says the company's new diagnostic system beat generalist doctors on difficult cases in a peer-reviewed study, a milestone he frames as progress toward 'medical superintelligence,' per TechCrunch and The Verge.
Notably, most of the performance improvement appears to come from the foundation models underneath the system rather than Microsoft's own orchestration layer, raising questions about how defensible the product advantage actually is.
Healthcare is the highest-stakes proving ground for AI claims, and investors will want to know whether Microsoft's moat is the model or the wrapper. Leaders evaluating clinical AI vendors should separate marketing from the underlying model performance before committing budget.
The daily signal, curated. Get it in your inbox.
Subscribe on LinkedIn →